Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
CONCLUSIONS: Long-term treatment with cinacalcet in kidney transplant recipients with secondary hyperparathyroidism is effective in controlling hypercalcemia and correcting hypophosphatemia, without affecting graft function while being well-tolerated.
PMID: 29108515 [PubMed - as supplied by publisher]
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - Category: Transplant Surgery Authors: Zavvos V, Fyssa L, Papasotiriou M, Papachristou E, Ntrinias T, Savvidaki E, Goumenos DS Tags: Exp Clin Transplant Source Type: research
More News: Calcium | Cardiology | Cardiovascular | Gastroenterology | Heart | Hormones | Hyperparathyroidism | Kidney Transplant | Kidney Transplantation | Middle East Health | Phosphorus | Sensipar | Study | Transplant Surgery | Transplants | Urology & Nephrology